Moelis & Co
NYSE:MC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
49.08
80.49
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Moelis & Co
Moelis & Co
Net Issuance of Common Stock
Moelis & Co
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Moelis & Co
NYSE:MC
|
Net Issuance of Common Stock
-$11.3m
|
CAGR 3-Years
53%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Goldman Sachs Group Inc
NYSE:GS
|
Net Issuance of Common Stock
-$3.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
Morgan Stanley
NYSE:MS
|
Net Issuance of Common Stock
-$5.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Charles Schwab Corp
NYSE:SCHW
|
Net Issuance of Common Stock
$69m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Robinhood Markets Inc
NASDAQ:HOOD
|
Net Issuance of Common Stock
-$589m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Interactive Brokers Group Inc
NASDAQ:IBKR
|
Net Issuance of Common Stock
$3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Moelis & Co
Glance View
Founded in 2007 during a period of significant financial upheaval, Moelis & Co. charted its own course through turbulent waters, establishing itself as a stalwart in the investment banking arena. Specializing in providing strategic advice on mergers, acquisitions, recapitalizations, restructurings, and other critical financial matters, the firm has built a reputation for its sharp focus on advisory services. Unlike larger Wall Street banks engaged in a range of financial activities, Moelis & Co. prides itself on being an independent advisory-focused institution, insulating its advisory services from potential conflicts of interest that may arise in firms with trading and lending operations. This clear-cut focus enables the firm to offer unbiased advice, which has resonated well with a discerning clientele. The firm's revenue streams primarily flow from the fees charged for its advisory services. Working closely with companies, governments, and financial sponsors worldwide, Moelis & Co. leverages its extensive network and deep industry insight to tailor strategies that align with its clients' goals. These engagements often involve providing meticulous guidance through complex transactions, ensuring that clients can navigate their challenges with precision. The nature of their work implies that income may fluctuate with the ebbs and tides of deal-making cycles in the financial markets, yet the firm's agile model and seasoned advisors have consistently steered it towards sustainable profitability. This approach not only fortifies its standing in the market but also underscores its mission to build enduring client relationships founded on trust and integrity.
See Also
What is Moelis & Co's Net Issuance of Common Stock?
Net Issuance of Common Stock
-11.3m
USD
Based on the financial report for Sep 30, 2024, Moelis & Co's Net Issuance of Common Stock amounts to -11.3m USD.
What is Moelis & Co's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
23%
Over the last year, the Net Issuance of Common Stock growth was 76%. The average annual Net Issuance of Common Stock growth rates for Moelis & Co have been 53% over the past three years , 23% over the past five years .
You don't have any saved screeners yet
